腾盛博药-B(02137)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02137 腾盛博药-B

未开盘 11-18 16:08:08

1.080

+0.010

+0.93%

最高1.080	最低1.020	成交量96.25万
今开1.040	昨收1.070	日振幅5.61%
总市值7.89亿	流通市值7.89亿	总股本7.30亿
成交额101.37万	换手率0.13%	流通股本7.30亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02137","market":"HK","secType":"STK","nameCN":"腾盛博药-B","latestPrice":1.08,"timestamp":1731917288015,"preClose":1.07,"halted":0,"volume":962500,"delay":0,"floatShares":730437921,"shares":730437921,"eps":-0.25862643,"marketStatus":"未开盘","marketStatusCode":0,"change":0.01,"latestTime":"11-18 16:08:08","open":1.04,"high":1.08,"low":1.02,"amount":1013675,"amplitude":0.056075,"askPrice":1.08,"askSize":93500,"bidPrice":1.06,"bidSize":15000,"shortable":0,"etf":0,"ttmEps":-0.39207997574606535,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731979800000},"adr":0,"listingDate":1626105600000,"adjPreClose":1.07,"openAndCloseTimeList":[[1731893400000,1731902400000],[1731906000000,1731916800000]],"volumeRatio":0.7909442023907206,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02137","defaultTab":"news","newsList":[{"id":"2483331937","title":"好样的！见义勇为的市场监管干部洪志鑫","url":"https://stock-news.laohu8.com/highlight/detail?id=2483331937","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483331937?lang=zh_cn&edition=full","pubTime":"2024-11-15 14:41","pubTimestamp":1731652860,"startTime":"0","endTime":"0","summary":"泉州市食药认证监测中心的洪志鑫作为“见义勇为先进群体”代表参会并发言，鲤城区区长王克思为其颁发荣誉证书。提起洪志鑫见义勇为的事迹，还得从今年10月5日说起。洪志鑫松了一口气，跟司机沟通女乘客的病情，建议继续前往医院就诊。受救女乘客携家属给洪志鑫赠送锦旗。洪志鑫同志用自己的实际行动在危急时刻挽救他人生命，诠释了见义勇为的传统美德，充分体现了市场监管人员的优秀品质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-11-15/doc-incwcqvn3434495.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-11-15/doc-incwcqvn3434495.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","02137","BK1574","BK1587"],"gpt_icon":0},{"id":"2483398810","title":"腾盛博药-B(02137)下跌6.78%，报1.1元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483398810","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483398810?lang=zh_cn&edition=full","pubTime":"2024-11-14 14:40","pubTimestamp":1731566402,"startTime":"0","endTime":"0","summary":"11月14日，腾盛博药-B(02137)盘中下跌6.78%，截至14:40，报1.1元/股，成交107.3万元。腾盛博药生物科技有限公司主要业务是针对未被满足的病人需求和有限的治疗手段，开发针对感染性疾病和中枢神经系统疾病的创新疗法。该公司成立于2018年，现业务遍布罗利-达勒姆、旧金山湾区和中国的北京与上海，于2021年在香港交易所挂牌上市，股票代码为2137.HK。截至2023年年报，腾盛博药-B营业总收入61.7万元、净利润-1.75亿元。8月19日，腾盛博药-B披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/14144045283806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK1587","02137","BK1574"],"gpt_icon":0},{"id":"2483938888","title":"腾盛博药-B盘中异动 急速拉升6.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483938888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483938888?lang=zh_cn&edition=full","pubTime":"2024-11-14 09:44","pubTimestamp":1731548642,"startTime":"0","endTime":"0","summary":"2024年11月14日早盘09时44分，腾盛博药-B股票出现异动，股价急速上涨6.78%。截至发稿，该股报1.260港元/股，成交量15万股，换手率0.02%，振幅6.78%。腾盛博药-B股票所在的生物技术行业中，整体跌幅为0.27%。腾盛博药-B公司简介：腾盛博药生物科技有限公司是一家总部位于中国和美国主要从事传染病疗法研发业务的生物技术公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111409440298e42838&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111409440298e42838&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","02137","BK1574","BK1161"],"gpt_icon":0},{"id":"2483013077","title":"腾盛博药-B(02137)上涨9.26%，报1.18元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483013077","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483013077?lang=zh_cn&edition=full","pubTime":"2024-11-13 10:25","pubTimestamp":1731464707,"startTime":"0","endTime":"0","summary":"11月13日，腾盛博药-B(02137)盘中上涨9.26%，截至10:25，报1.18元/股，成交157.91万元。腾盛博药生物科技有限公司主要业务是针对未被满足的病人需求和有限的治疗手段，开发针对感染性疾病和中枢神经系统疾病的创新疗法。该公司成立于2018年，现业务遍布罗利-达勒姆、旧金山湾区和中国的北京与上海，于2021年在香港交易所挂牌上市，股票代码为2137.HK。截至2023年年报，腾盛博药-B营业总收入61.7万元、净利润-1.75亿元。8月19日，腾盛博药-B披露2024财年中报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/13102545231708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02137","BK1574","BK1587","BK1161"],"gpt_icon":0},{"id":"2483189090","title":"腾盛博药-B盘中异动 早盘大幅上涨6.48%报1.150港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483189090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483189090?lang=zh_cn&edition=full","pubTime":"2024-11-13 09:54","pubTimestamp":1731462890,"startTime":"0","endTime":"0","summary":"2024年11月13日早盘09时54分，腾盛博药-B股票出现波动，股价急速拉升6.48%。截至发稿，该股报1.150港元/股，成交量17.5万股，换手率0.02%，振幅6.48%。资金方面，该股资金流入14.0255万港元，流出3.2685万港元。腾盛博药-B股票所在的生物技术行业中，整体跌幅为1.50%。其相关个股中，腾盛博药-B、贝康医疗-B、歌礼制药-B涨幅较大，振幅较大的相关个股有宜明昂科-B、来凯医药-B、乐普生物-B，振幅分别为16.54%、9.70%、7.61%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113095450a232026c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113095450a232026c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02137","BK1161","BK1587"],"gpt_icon":0},{"id":"2481179906","title":"全国人大常委会：严立淼、刘文杰的代表资格自然终止","url":"https://stock-news.laohu8.com/highlight/detail?id=2481179906","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481179906?lang=zh_cn&edition=full","pubTime":"2024-11-08 20:17","pubTimestamp":1731068223,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1587","BK1161","02137","BK1574"],"gpt_icon":0},{"id":"2480436310","title":"腾盛博药-B盘中异动 早盘股价大涨5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480436310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480436310?lang=zh_cn&edition=full","pubTime":"2024-11-04 09:37","pubTimestamp":1730684249,"startTime":"0","endTime":"0","summary":"2024年11月04日早盘09时37分，腾盛博药-B股票出现波动，股价急速拉升5.83%。截至发稿，该股报1.090港元/股，成交量8.6万股，换手率0.01%，振幅5.83%。腾盛博药-B股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，云顶新耀-B、腾盛博药-B、昭衍新药涨幅较大，振幅较大的相关个股有方达控股、科济药业-B、腾盛博药-B，振幅分别为12.36%、7.31%、5.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104093729971a401f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"d687eec3b8c9c2cb79b216c38e84ebbe","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104093729971a401f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02137","BK1574","BK1587"],"gpt_icon":0},{"id":"2478136461","title":"腾盛博药-B授出合共1466万份购股权及155.5万份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2478136461","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478136461?lang=zh_cn&edition=full","pubTime":"2024-10-28 08:03","pubTimestamp":1730073788,"startTime":"0","endTime":"0","summary":"腾盛博药-B公布，内容涉及根据首次公开发售前股份激励计划及首次公开发售后购股权计划的条款，向若干现有购股权受让人授出合共1142.6万份基于里程碑的购股权及合共3227.6万份随时间归属的购股权；及根据首次公开发售后股份奖励计划的条款，向若干现有受限制股份单位受让人授出合共228.3万个基于里程碑的受限制股份单位。截至本公告刊发日期，上述购股权均未获行使，上述受限制股份单位亦均未归属。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-28/doc-incuacvp5829999.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-28/doc-incuacvp5829999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1161","BK1587","02137","BK1574"],"gpt_icon":0},{"id":"2478934430","title":"腾盛博药-B(02137)授出合共1466万份购股权及155.5万份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2478934430","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478934430?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:54","pubTimestamp":1729868057,"startTime":"0","endTime":"0","summary":"截至本公告刊发日期，上述购股权均未获行使，上述受限制股份单位亦均未归属。基于里程碑的购股权及受限制股份单位是根据首次公开发售后购股权计划及首次公开发售后股份奖励计划授出，其归属条件与公司若干管线项目的预定研发活动及商业里程碑相关。此外，于2024年 10月25日，公司根据2023年购股权计划条款向75名购股权受让人授出合共1466万份购股权，并根据2023年股份奖励计划条款向6名受限制股份单位受让人授出合共155.5万份受限制股份单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1200492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1587","02137","BK1574"],"gpt_icon":0},{"id":"2476229277","title":"知名浙商去世，年仅56岁","url":"https://stock-news.laohu8.com/highlight/detail?id=2476229277","media":"都市快报橙柿互动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476229277?lang=zh_cn&edition=full","pubTime":"2024-10-19 22:32","pubTimestamp":1729348326,"startTime":"0","endTime":"0","summary":"10月19日，严立淼同志治丧委员会发布讣告，亿联控股集团创始人、董事长严立淼同志因病医治无效，于2024年10月18日23时30分逝世，享年56岁。中国共产党党员，全国脱贫攻坚先进个人，中华慈善家获得者，第十四届全国人大代表，全国工商联常委、五金机电商会会长，天津市工商联副主席，亿联控股集团创始人、董事长……讣告简短...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OKQ4JGBOjF6MC0cWWvHxJSb1svxgvzOtehndGz3ulcmGYAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OKQ4JGBOjF6MC0cWWvHxJSb1svxgvzOtehndGz3ulcmGYAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241019A085H400","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241019A085H400","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1161","02137","BK1574","BK1587"],"gpt_icon":0},{"id":"2476750801","title":"严立淼同志逝世","url":"https://stock-news.laohu8.com/highlight/detail?id=2476750801","media":"长安街知事","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476750801?lang=zh_cn&edition=full","pubTime":"2024-10-19 21:26","pubTimestamp":1729344398,"startTime":"0","endTime":"0","summary":"10月19日，严立淼同志治丧委员会发布讣告，亿联控股集团创始人、董事长严立淼同志因病医治无效，于2024年10月18日23时30分逝世，享年56岁。严立淼 资料图严立淼出生于1968年8月，浙江温州人，亿联控股集团创始人、董事长。20多年前，严立淼怀着梦想，白手起家创立了亿联控股集团，并带领企业一步步发展壮大。作为企业家，严...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OEdqhDIke9q7J1eHbZVUDCCbNHV5kdtlAXVhvbV0aPEisAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OEdqhDIke9q7J1eHbZVUDCCbNHV5kdtlAXVhvbV0aPEisAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241019A07TKY00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241019A07TKY00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1161","BK1587","02137","BK1574"],"gpt_icon":0},{"id":"2476420930","title":"腾盛博药-B(02137)上涨5.83%，报1.09元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2476420930","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476420930?lang=zh_cn&edition=full","pubTime":"2024-10-18 14:54","pubTimestamp":1729234466,"startTime":"0","endTime":"0","summary":"10月18日，腾盛博药-B(02137)盘中上涨5.83%，截至14:54，报1.09元/股，成交204.07万元。腾盛博药生物科技有限公司主要业务是针对未被满足的病人需求和有限的治疗手段，开发针对感染性疾病和中枢神经系统疾病的创新疗法。该公司成立于2018年，现业务遍布罗利-达勒姆、旧金山湾区和中国的北京与上海，于2021年在香港交易所挂牌上市，股票代码为2137.HK。截至2023年年报，腾盛博药-B营业总收入61.7万元、净利润-1.75亿元。8月19日，腾盛博药-B披露2024财年中报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/18145444152887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1587","02137","BK1574","BK1161"],"gpt_icon":0},{"id":"2476420338","title":"腾盛博药-B盘中异动 下午盘快速拉升5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476420338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476420338?lang=zh_cn&edition=full","pubTime":"2024-10-18 14:54","pubTimestamp":1729234462,"startTime":"0","endTime":"0","summary":"2024年10月18日下午盘14时54分，腾盛博药-B股票出现波动，股价大幅拉升5.83%。截至发稿，该股报1.090港元/股，成交量193.2万股，换手率0.26%，振幅8.74%。腾盛博药-B股票所在的生物技术行业中，整体涨幅为2.40%。腾盛博药-B公司简介：腾盛博药生物科技有限公司是一家总部位于中国和美国主要从事传染病疗法研发业务的生物技术公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101814542298e3d35c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101814542298e3d35c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1161","02137","BK1574"],"gpt_icon":0},{"id":"2475343573","title":"腾盛博药创新药三年跌宕路：股价破发90%多，“押宝”乙肝赛道，核心品种徘徊于Ⅱ期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2475343573","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475343573?lang=zh_cn&edition=full","pubTime":"2024-10-15 18:32","pubTimestamp":1728988373,"startTime":"0","endTime":"0","summary":"上市三年，腾盛博药-B（2137.HK）经历了一场从高光时刻到逐渐被市场边缘化的戏剧性转变，令人唏嘘不已。腾盛博药-B（2137.HK）曾因首款国产新冠中和抗体药而备受资本追捧。上市三个月内，该公司股价最高至52.60港元/股，总市值超363亿港元（折合人民币300.95亿元）。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202410153206793830.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06978","BK1574","BK1161","BK1587","02137"],"gpt_icon":0},{"id":"2475555293","title":"腾盛博药-B盘中异动 大幅跳水5.31%报1.070港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475555293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475555293?lang=zh_cn&edition=full","pubTime":"2024-10-15 13:29","pubTimestamp":1728970163,"startTime":"0","endTime":"0","summary":"2024年10月15日下午盘13时29分，腾盛博药-B股票出现波动，股价快速跳水5.31%。截至发稿，该股报1.070港元/股，成交量54.0518万股，换手率0.07%，振幅6.19%。资金方面，该股资金流入5.257万港元，流出43.107万港元。腾盛博药-B股票所在的生物技术行业中，整体跌幅为0.85%。其相关个股中，华康生物医学、绿竹生物-B、嘉和生物-B涨幅较大，振幅较大的相关个股有来凯医药-B、思路迪医药股份、科济药业-B，振幅分别为16.08%、12.31%、11.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015132923ab6a280b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015132923ab6a280b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1587","02137","BK1574"],"gpt_icon":0},{"id":"2475387677","title":"腾盛博药-B(02137)下跌5.0%，报1.14元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2475387677","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475387677?lang=zh_cn&edition=full","pubTime":"2024-10-14 14:15","pubTimestamp":1728886524,"startTime":"0","endTime":"0","summary":"10月14日，腾盛博药-B(02137)盘中下跌5.0%，截至14:15，报1.14元/股，成交114.27万元。腾盛博药生物科技有限公司主要业务是针对未被满足的病人需求和有限的治疗手段，开发针对感染性疾病和中枢神经系统疾病的创新疗法。该公司成立于2018年，现业务遍布罗利-达勒姆、旧金山湾区和中国的北京与上海，于2021年在香港交易所挂牌上市，股票代码为2137.HK。截至2023年年报，腾盛博药-B营业总收入61.7万元、净利润-1.75亿元。8月19日，腾盛博药-B披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/14141543962206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02137","BK1161","BK1574","BK1587"],"gpt_icon":0},{"id":"2475809644","title":"腾盛博药-B盘中异动 股价大跌5.83%报1.130港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475809644","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475809644?lang=zh_cn&edition=full","pubTime":"2024-10-14 09:56","pubTimestamp":1728870980,"startTime":"0","endTime":"0","summary":"2024年10月14日早盘09时56分，腾盛博药-B股票出现异动，股价大幅下挫5.83%。截至发稿，该股报1.130港元/股，成交量25.85万股，换手率0.04%，振幅5.83%。资金方面，该股资金流入6.0525万港元，流出21.1255万港元。腾盛博药-B股票所在的生物技术行业中，整体跌幅为2.66%。其相关个股中，盛禾生物-B、绿竹生物-B、三叶草生物-B涨幅较大，振幅较大的相关个股有科济药业-B、荃信生物-B、宜明昂科-B，振幅分别为14.32%、11.44%、9.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101409562098e3c1c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101409562098e3c1c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","BK1161","02137"],"gpt_icon":0},{"id":"2474765832","title":"腾盛博药-B(02137)下跌5.56%，报1.19元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2474765832","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474765832?lang=zh_cn&edition=full","pubTime":"2024-10-10 14:00","pubTimestamp":1728540029,"startTime":"0","endTime":"0","summary":"10月10日，腾盛博药-B(02137)盘中下跌5.56%，截至14:00，报1.19元/股，成交188.2万元。腾盛博药生物科技有限公司主要业务是针对未被满足的病人需求和有限的治疗手段，开发针对感染性疾病和中枢神经系统疾病的创新疗法。该公司成立于2018年，现业务遍布罗利-达勒姆、旧金山湾区和中国的北京与上海，于2021年在香港交易所挂牌上市，股票代码为2137.HK。截至2023年年报，腾盛博药-B营业总收入61.7万元、净利润-1.75亿元。8月19日，腾盛博药-B披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/10140043869433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK1587","02137","BK1574"],"gpt_icon":0},{"id":"2474737581","title":"腾盛博药-B盘中异动 大幅下跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474737581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474737581?lang=zh_cn&edition=full","pubTime":"2024-10-10 10:08","pubTimestamp":1728526133,"startTime":"0","endTime":"0","summary":"2024年10月10日早盘10时08分，腾盛博药-B股票出现波动，股价大幅跳水5.56%。截至发稿，该股报1.190港元/股，成交量62万股，换手率0.08%，振幅7.14%。腾盛博药-B股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，科济药业-B、北海康成-B、正大企业国际涨幅较大，振幅较大的相关个股有科济药业-B、乐普生物-B、创胜集团-B，振幅分别为17.56%、13.69%、10.53%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010100853ab69036f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010100853ab69036f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02137","BK1161","BK1574","BK1587"],"gpt_icon":0},{"id":"2474253727","title":"腾盛博药-B盘中异动 早盘急速下跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474253727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474253727?lang=zh_cn&edition=full","pubTime":"2024-10-09 10:02","pubTimestamp":1728439377,"startTime":"0","endTime":"0","summary":"2024年10月09日早盘10时02分，腾盛博药-B股票出现波动，股价快速下挫5.43%。截至发稿，该股报1.220港元/股，成交量35.9万股，换手率0.05%，振幅6.98%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。腾盛博药-B股票所在的生物技术行业中，整体涨幅为1.32%。腾盛博药-B公司简介：腾盛博药生物科技有限公司是一家总部位于中国和美国主要从事传染病疗法研发业务的生物技术公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410091002579719f1b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410091002579719f1b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02137","BK1587","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.briibio.com","stockEarnings":[{"period":"1week","weight":0.0189},{"period":"1month","weight":0.0093},{"period":"3month","weight":0.125},{"period":"6month","weight":-0.2117},{"period":"1year","weight":-0.5925},{"period":"ytd","weight":-0.5263}],"compareEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":-0.059},{"period":"3month","weight":0.118},{"period":"6month","weight":0.0198},{"period":"1year","weight":0.1216},{"period":"ytd","weight":0.1484}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"腾盛博药生物科技有限公司是一家总部位于中国和美国主要从事传染病疗法研发业务的生物技术公司。该公司的产品应用于传染病（如乙型肝炎病毒(HBV)、人类免疫缺陷病毒(HIV)、多重耐药(MDR)或广泛耐药性(XDR)革兰氏阴性菌感染）及其他具有重大公共卫生负担的疾病（如中枢神经系统(CNS)疾病）。该公司还开发用于COVID-19等的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.139084},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.166803},{"month":3,"riseRate":0,"avgChangeRate":-0.321072},{"month":4,"riseRate":0.333333,"avgChangeRate":0.044149},{"month":5,"riseRate":0,"avgChangeRate":-0.067206},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.097476},{"month":7,"riseRate":1,"avgChangeRate":0.066427},{"month":8,"riseRate":0.25,"avgChangeRate":0.023974},{"month":9,"riseRate":0.5,"avgChangeRate":-0.020754},{"month":10,"riseRate":0.25,"avgChangeRate":-0.137315},{"month":11,"riseRate":1,"avgChangeRate":0.395569},{"month":12,"riseRate":0,"avgChangeRate":-0.197537}],"exchange":"SEHK","name":"腾盛博药-B","nameEN":"BRII - B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"腾盛博药-B(02137)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供腾盛博药-B(02137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"腾盛博药-B,02137,腾盛博药-B股票,腾盛博药-B股票老虎,腾盛博药-B股票老虎国际,腾盛博药-B行情,腾盛博药-B股票行情,腾盛博药-B股价,腾盛博药-B股市,腾盛博药-B股票价格,腾盛博药-B股票交易,腾盛博药-B股票购买,腾盛博药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"腾盛博药-B(02137)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供腾盛博药-B(02137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}